&bgr;-blockers in heart failure: recently completed and ongoing clinical trials

Author： McAreavey D.   Exner D.V.   Curtin E.L.   Domanski M.J.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.2, 2000-02, pp. : 415-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carvedilol versus other &bgr;-blockers in heart failure

By Doggrell S.A.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 971-980

Informa Healthcare

Access to resources Recommend Favorite

Planned, ongoing and recently completed clinical trials for atherosclerosis prevention and regression: an update

By Mellies M.   McGovern M.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 1, 1997-01 ,pp. : 31-50

Informa Healthcare

Access to resources Recommend Favorite

-Blockers in Heart Failure: The ‘New Wave’ of Clinical Trials

By Krum H.  

Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. : 203-210

Adis International

Access to resources Recommend Favorite

Fibrinolytic and antithrombotic regimens in recently completed, ongoing and planned clinical trials in myocardial infarction

By Jong P.   Langer A.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. : 1453-1465

Informa Healthcare

Access to resources Recommend Favorite

The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine: a review of recently completed clinical trials

By Salam Amar M   Al-Mousa Eyas N  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1423-1430

Informa Healthcare

Access to resources Recommend Favorite